Last reviewed · How we verify
TA-NIC
At a glance
| Generic name | TA-NIC |
|---|---|
| Sponsor | Celtic Pharma Development Services |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users (PHASE1)
- Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TA-NIC CI brief — competitive landscape report
- TA-NIC updates RSS · CI watch RSS
- Celtic Pharma Development Services portfolio CI